BCLS II Investco LP 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-17 5:35 pm Purchase |
2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
BCLS II Investco LP | 10,719,110 13.000% |
5,342,754 (+99.38%) |
Filing |
| 2024-03-01 4:30 pm Unchanged |
2024-02-28 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
BCLS II Investco LP | 5,376,356 6.000% |
0 (Unchanged) |
Filing |
| 2023-06-13 5:04 pm Purchase |
2023-06-09 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
BCLS II Investco LP | 5,376,356 6.600% |
1,376,356 (+34.41%) |
Filing |
| 2022-12-02 4:24 pm Purchase |
2022-11-22 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
BCLS II Investco LP | 4,000,000 4.900% |
4,000,000 (New Position) |
Filing |